CORD-19:12d35c12218f230c49f4dc892814ba9f1037f251 / 32021-32223 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/12d35c12218f230c49f4dc892814ba9f1037f251","sourcedb":"CORD-19","sourceid":"12d35c12218f230c49f4dc892814ba9f1037f251","text":"Furthermore, these novel vaccine vectors have been increasingly used, again with varying degrees of success, in the development of therapeutic vaccines against several common cancer antigens (81, 100) .","tracks":[{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T154","span":{"begin":0,"end":202},"obj":"Sentence"}],"attributes":[{"subj":"T154","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T154","span":{"begin":0,"end":202},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T154","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19-PD-HP","denotations":[{"id":"T16","span":{"begin":175,"end":181},"obj":"Phenotype"}],"attributes":[{"id":"A16","pred":"hp_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/HP_0002664"},{"subj":"T16","pred":"source","obj":"CORD-19-PD-HP"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T124","span":{"begin":175,"end":181},"obj":"Disease"},{"id":"T4844","span":{"begin":175,"end":181},"obj":"Disease"}],"attributes":[{"id":"A124","pred":"mondo_id","subj":"T124","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"},{"id":"A28682","pred":"mondo_id","subj":"T4844","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"},{"subj":"T124","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T4844","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19_Custom_license_subset","color":"#ec93ba","default":true},{"id":"CORD-19-Sentences","color":"#93d4ec"},{"id":"CORD-19-PD-HP","color":"#ecea93"},{"id":"CORD-19-PD-MONDO","color":"#d093ec"}]}]}}